查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1387352

恐慌症市場報告：2030 年趨勢、預測與競爭分析

Panic Disorders Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

恐慌症趨勢與預測

預計 2024 年至 2030 年，全球恐慌症市場將以 7.8% 的複合年成長率成長。這個市場的主要促進因素是受恐慌症影響的患者數量不斷增加，以及人們對心理健康的認知和配合措施不斷提高。全球恐慌症市場的未來前景看好，醫院、精神衛生保健中心和精神病院市場存在商機。

恐慌症市場洞察

Lucintel 預測，錠劑將繼續佔據很大一部分市場，因為它們能夠幫助減少恐慌發作的頻率和嚴重程度。

在這個市場中，精神健康保健中心將繼續成為最大的部分，因為它們提供廣泛的服務，包括個人和團體治療、藥物管理和危機干預。

由於人們對心理健康的認知不斷提高以及擁有高度發展的醫療基礎設施，北美在預測期內可能仍是最大的市場。

本報告回答了 11 個關鍵問題：

  • Q.1. 區隔市場中最有前途和高成長的機會是什麼？
  • Q.2.哪個區隔市場將以更快的速度成長？為什麼？
  • Q.3.哪些地區未來會出現更快的成長？為什麼？
  • Q.4. 影響市場動態的主要因素有哪些？市場的主要課題和商業風險是什麼？
  • Q.5. 這個市場的商業風險和競爭威脅是什麼？
  • Q.6.這個市場有哪些新趨勢？為什麼？
  • Q.7.市場客戶需求有何改變？
  • Q.8. 該市場有哪些新發展以及哪些公司處於領先地位？
  • Q.9.這個市場的主要企業有哪些？主要企業採取哪些策略配合措施來發展業務？
  • Q.10. 該市場上的競爭產品有哪些？由於材料或產品替代而導致市場佔有率下降的威脅有多大？
  • Q.11.過去五年發生了哪些併購事件，對產業產生了哪些影響？

目錄

第1章執行摘要

第2章全球恐慌症市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與課題

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球恐慌症市場趨勢（2018-2023）與預測（2024-2030）
  • 全球恐慌症市場（依劑量）
    • 錠劑
    • 注射
    • 其他
  • 依類型分類的全球恐慌症市場
    • 恐懼症
    • 社交恐懼症
    • 強迫性精神官能症
    • 躁鬱症
    • 創傷後壓力症候群（PTSD）
    • 特定恐懼症
    • 整體焦慮症
    • 重度憂鬱症
  • 以最終用途分類的全球恐慌症市場
    • 醫院
    • 精神保健中心
    • 精神病院
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 依地區分類的全球恐慌症市場
  • 北美恐慌症市場
  • 歐洲恐慌症市場
  • 亞太恐慌症市場
  • 其他地區恐慌症市場

第5章競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球恐慌症市場成長機會（依劑量）
    • 依類型分類的全球恐慌症市場成長機會
    • 依最終用途分類的全球恐慌症市場成長機會
    • 依地區分類的全球恐慌症市場成長機會
  • 全球恐慌症市場新趨勢
  • 戰略分析
    • 新產品開發
    • 全球恐慌症市場容量擴張
    • 全球恐慌症收購和合資企業
    • 認證和許可

第7章主要企業概況

  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Mylan
  • AstraZeneca
  • Abbott
  • Baxter
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche
  • GlaxoSmithKline
簡介目錄

Panic Disorders Trends and Forecast

The future of the global panic disorders market looks promising with opportunities in the hospitals, mental healthcare centres, and asylums markets. The global panic disorders market is expected to grow with a CAGR of 7.8% from 2024 to 2030. The major drivers for this market are increasing number of patients suffering from panic disorders and rising awareness and initiatives for mental health.

A more than 150-page report is developed to help in your business decisions.

Panic Disorders by Segment

The study includes a forecast for the global panic disorders by dosage, type, end use, and region.

Panic Disorders Market by Dosage [Shipment Analysis by Value from 2018 to 2030]:

  • Tablets
  • Injections
  • Others

Panic Disorders Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Agoraphobia
  • Social Anxiety Disorder
  • Obsessive-Compulsive Disorder
  • Bipolar Disorder
  • Post-Traumatic Stress Disorder
  • Specific Phobias
  • Generalized Anxiety Disorder
  • Major Depressive Disorder

Panic Disorders Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Mental Healthcare Centres
  • Asylums
  • Others

Panic Disorders Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Panic Disorders Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies panic disorders companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the panic disorders companies profiled in this report include-

  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Mylan
  • Astrazeneca
  • Abbott
  • Baxter
  • Bristol-Myers Squibb Company
  • Eli Lilly And Company
  • F. Hoffmann-La Roche
  • Glaxosmithkline

Panic Disorders Market Insights

Lucintel forecasts that tablets will remain the larger segment as it helps in reducing the frequency and severity of panic attacks.

Within this market, mental healthcare center will remain the largest segment as it delivers wide range of services, such as individual and group therapy, medication management, and crisis intervention.

North America will remain the largest segment over the forecast period due to rising awareness towards mental health and presence of highly developed healthcare infrastructure in the region.

Features of the Global Panic Disorders Market

Market Size Estimates: Panic disorders market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Panic disorders market size by dosage, type, end use, and region in terms of value ($B).

Regional Analysis: Panic disorders market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different dosage, types, end uses, and regions for the panic disorders market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the panic disorders market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the growth forecast for panic disorders market?

Answer: The global panic disorders market is expected to grow with a CAGR of 7.8% from 2024 to 2030.

Q2. What are the major drivers influencing the growth of the panic disorders market?

Answer: The major drivers for this market are increasing number of patients suffering from panic disorders and rising awareness and initiatives for mental health.

Q3. What are the major segments for panic disorders market?

Answer: The future of the panic disorders market looks promising with opportunities in the hospitals, mental healthcare centres, and asylums markets.

Q4. Who are the key panic disorders market companies?

Answer: Some of the key panic disorders companies are as follows:

  • Teva Pharmaceutical Industries
  • Sun Pharmaceutical Industries
  • Mylan
  • Astrazeneca
  • Abbott
  • Baxter
  • Bristol-Myers Squibb Company
  • Eli Lilly And Company
  • F. Hoffmann-La Roche
  • Glaxosmithkline

Q5. Which panic disorders market segment will be the largest in future?

Answer: Lucintel forecasts that tablets will remain the larger segment as it helps in reducing the frequency and severity of panic attacks.

Q6. In panic disorders market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest segment over the forecast period due to rising awareness towards mental health and presence of highly developed healthcare infrastructure in the region.

Q7. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the panic disorders market by dosage (tablets, injections, and others), type (agoraphobia, social anxiety disorder, obsessive-compulsive disorder, bipolar disorder, post-traumatic stress disorder, specific phobias, generalized anxiety disorder, and major depressive disorder), end use (hospitals, mental healthcare centres, asylums, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Panic Disorders Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Panic Disorders Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Panic Disorders Market by Dosage
    • 3.3.1: Tablets
    • 3.3.2: Injections
    • 3.3.3: Others
  • 3.4: Global Panic Disorders Market by Type
    • 3.4.1: Agoraphobia
    • 3.4.2: Social Anxiety Disorder
    • 3.4.3: Obsessive-Compulsive Disorder
    • 3.4.4: Bipolar Disorder
    • 3.4.5: Post-Traumatic Stress Disorder
    • 3.4.6: Specific Phobias
    • 3.4.7: Generalized Anxiety Disorder
    • 3.4.8: Major Depressive Disorder
  • 3.5: Global Panic Disorders Market by End Use
    • 3.5.1: Hospitals
    • 3.5.2: Mental Healthcare Centres
    • 3.5.3: Asylums
    • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Panic Disorders Market by Region
  • 4.2: North American Panic Disorders Market
    • 4.2.2: North American Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others
  • 4.3: European Panic Disorders Market
    • 4.3.1: European Panic Disorders Market by Dosage: Tablets, Injections, and Others
    • 4.3.2: European Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others
  • 4.4: APAC Panic Disorders Market
    • 4.4.1: APAC Panic Disorders Market by Dosage: Tablets, Injections, and Others
    • 4.4.2: APAC Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others
  • 4.5: ROW Panic Disorders Market
    • 4.5.1: ROW Panic Disorders Market by Dosage: Tablets, Injections, and Others
    • 4.5.2: ROW Panic Disorders Market by End Use: Hospitals, Mental Healthcare Centres, Asylums, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Panic Disorders Market by Dosage
    • 6.1.2: Growth Opportunities for the Global Panic Disorders Market by Type
    • 6.1.3: Growth Opportunities for the Global Panic Disorders Market by End Use
    • 6.1.4: Growth Opportunities for the Global Panic Disorders Market by Region
  • 6.2: Emerging Trends in the Global Panic Disorders Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Panic Disorders Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Panic Disorders Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Teva Pharmaceutical Industries
  • 7.2: Sun Pharmaceutical Industries
  • 7.3: Mylan
  • 7.4: AstraZeneca
  • 7.5: Abbott
  • 7.6: Baxter
  • 7.7: Bristol-Myers Squibb Company
  • 7.8: Eli Lilly and Company
  • 7.9: F. Hoffmann-La Roche
  • 7.10: GlaxoSmithKline